(Q34248885)

31 July 2017

1 reference

title

Live attenuated vaccines against influenza; an historical review (English)

1 reference

31 July 2017

1 reference

Wareing MD

1

1 reference

31 July 2017

Tannock GA

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

19

1 reference

31 July 2017

issue

25-26

1 reference

31 July 2017

page(s)

3320-3330

1 reference

High growth reassortant influenza vaccine viruses: new approaches to their control

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Morphological and biochemical characterization of influenza vaccines commercially available in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Attenuation of human influenza a viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Recombinant WRL 105 strain live attenuated influenza vaccine. Immunogenicity, reactivity, and transmissibility

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Adaptation and Growth Characteristics of Influenza Virus at 25° C

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Development of novel influenza virus vaccines and vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Temperature-Sensitive Mutants of Influenza Virus. I. Behavior in Tissue Culture and in Experimental Animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

The production of live attenuated influenza A strains by recombination with A/Okuda/57 (H2N2).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Gene constellation of live influenza A vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Characterization of the attenuating M and NP gene segments of the avian influenza A/Mallard/78 virus during in vitro production of avian-human reassortant vaccine viruses and after replication in humans and primates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Reverse genetics of negative-strand RNA viruses: closing the circle

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

RNA polymerase I-mediated expression of influenza viral RNA molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Generation of influenza A viruses entirely from cloned cDNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

"Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Synthetic Recombinant Vaccines against Viral Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Enteric immunization of mice against influenza with recombinant vaccinia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Sequence comparisons of A/AA/6/60 influenza viruses: mutations which may contribute to attenuation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Analysis of Genome Composition and Reactogenicity of Recombinants of Cold-adapted and Virulent Virus Strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Cold-adapted live attenuated influenza vaccines developed in Russia: can they contribute to meeting the needs for influenza control in other countries?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Development and characterization of cold-adapted viruses for use as live virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Variability in infectivity of cold-adapted recombinant influenza virus vaccines in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Dose response of influenza A/Washington/897/80 (H3N2) cold-adapted reassortant virus in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Live attenuated influenza A virus vaccines in children: results of a field trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Trials of Influenza A/New Jersey/76 Virus Vaccine in Normal Children: An Overview of Age-Related Antigenicity and Reactogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

A review of attenuation of influenza viruses by genetic manipulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Interference following dual inoculation with influenza A (H3N2) and (H1N1) viruses in ferrets and volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Protective responses in mice to vaccination with multiply administered cold-adapted influenza vaccine reassortants and wild-type viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Comparison of monovalent and trivalent live attenuated influenza vaccines in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Cold-adapted recombinant influenza A virus vaccines in seronegative young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Advances in influenza virus vaccine research

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900045-7

7 January 2021

10.1016/S0264-410X(01)00045-7

Identifiers

DOI

1 reference

31 July 2017

1 reference